HCQ during pregnancy may prevent congenital heart block

HCQ during pregnancy may prevent congenital heart block

(HealthDay)—For anti-SSA/Ro-positive mothers with a previous pregnancy complicated by congenital heart block (CHB), hydroxychloroquine may reduce the recurrence of CHB, according to a study published in the July 21 issue of the Journal of the American College of Cardiology.

Peter Izmirly, M.D., from the New York University School of Medicine in New York City, and colleagues recruited anti-SSA/Ro-positive mothers with a previous pregnancy complicated by CHB for a two-stage clinical trial (19 first stage and 35 second stage). Patients received 400 mg daily of from before completion of gestational week 10 through pregnancy.

The researchers found that four of 54 pregnancies (7.4 percent) resulted in a primary outcome of second-degree or third-degree CHB any time during in the intention-to-treat analysis. This was lower than the historical rate of recurrence of CHB of 18 percent. Nine mothers took potentially confounding medications after enrollment but before the primary outcome and were therefore replaced with nine additional mothers who were recruited and followed an identical protocol. In the per-protocol analysis, four of 54 fetuses (7.4 percent) developed a primary outcome. Secondary outcomes included one case of mild endocardial fibroelastosis and four cases of cutaneous neonatal lupus.

"Testing for anti-SSA/Ro antibodies is not part of the normal screening of , but it should now be considered," a coauthor said in a statement. "One implication of our findings is that hydroxychloroquine could be effective in preventing CHB in newborns of first-time, pregnant women with anti-SSA/Ro antibodies, which could change the way we evaluate all pregnancies regardless of a mother's health."


Explore further

Physicians should consider HCQ to reduce the risk of recurrent congenital heart block

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2020 HealthDay. All rights reserved.

Citation: HCQ during pregnancy may prevent congenital heart block (2020, July 15) retrieved 15 August 2020 from https://medicalxpress.com/news/2020-07-hcq-pregnancy-congenital-heart-block.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments